Dynamic behavior of metabolic syndrome progression: a comprehensive systematic review on recent discoveries.
Pezhman BagheriDavood KhaliliMozhgan SeifAbbas RezaianzadehPublished in: BMC endocrine disorders (2021)
Among the components of the MetS, dyslipidemia and hypertension seems to be the main developer components in natural history of the MetS. Also, in this chain, the most likely combination over time that determines the future status of people seems to be the combination of dyslipidemia with obesity or hyperglycemia. However, more research is needed.